Fact and fiction in tuberculosis vaccine research: 10 years later
- 1 August 2011
- journal article
- review article
- Published by Elsevier BV in The Lancet Infectious Diseases
- Vol. 11 (8), 633-640
- https://doi.org/10.1016/s1473-3099(11)70146-3
Abstract
No abstract availableKeywords
This publication has 80 references indexed in Scilit:
- Extended safety and efficacy studies of a live attenuated double leucine and pantothenate auxotroph of Mycobacterium tuberculosis as a vaccine candidateVaccine, 2011
- A Defined Tuberculosis Vaccine Candidate Boosts BCG and Protects Against Multidrug-Resistant Mycobacterium tuberculosisScience Translational Medicine, 2010
- A window into third-generation sequencingHuman Molecular Genetics, 2010
- An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosisNature, 2010
- Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnosticsProceedings of the National Academy of Sciences, 2009
- A New Recombinant Bacille Calmette‐Guérin Vaccine Safely Induces Significantly Enhanced Tuberculosis‐Specific Immunity in Human VolunteersThe Journal of Infectious Diseases, 2008
- Eliminating human tuberculosis in the twenty-first centuryJournal of The Royal Society Interface, 2007
- Poor correlation between BCG vaccination-induced T cell responses and protection against tuberculosisProceedings of the National Academy of Sciences, 2007
- M. tuberculosis and M. leprae Translocate from the Phagolysosome to the Cytosol in Myeloid CellsCell, 2007
- Translational Mini-Review Series on Vaccines:
Development and evaluation of improved vaccines against tuberculosisClinical and Experimental Immunology, 2007